n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine has been researched along with danazol in 1 studies
| Studies (n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine) | Trials (n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine) | Recent Studies (post-2010) (n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine) | Studies (danazol) | Trials (danazol) | Recent Studies (post-2010) (danazol) |
|---|---|---|---|---|---|
| 25 | 0 | 12 | 2,402 | 288 | 279 |
| Protein | Taxonomy | n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine (IC50) | danazol (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Glucocorticoid receptor | Homo sapiens (human) | 4.314 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.019 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 4.314 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 5.698 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.3 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.012 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 4.314 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 4.314 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 5.698 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 4.314 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 8.85 | |
| Cytochrome P450 2J2 | Homo sapiens (human) | 0.0317 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 6.842 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
1 other study(ies) available for n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine and danazol
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |